The right medicine,
matched to the
patient's genes.
Nuhlis reads a 60-gene pharmacogenomic panel at the point of care and its AI turns the result into genotype, phenotype and prescribing guidance — so clinicians dose right the first time. One test, referenced for a lifetime of safer prescribing.
Invitation only. Access is limited to invited clinicians, pharmacists and partners.
Member sign in
Enter the credentials tied to your invitation.
Need access? Contact your Nuhlis administrator.
Three connected steps
Collect & read
A blood, saliva or buccal sample is processed in a single-use cartridge; the shared point-of-care analyzer reads the 60-gene panel in about 30 minutes.
AI interpretation
The device sends only genotype calls. Nuhlis derives the metabolizer phenotype and clinical impact for every gene through a guideline-driven engine (CPIC / PharmVar / FDA).
Prescription guidance
For any drug, the app returns a dose factor and a prescribe / caution / avoid decision, and prints a Nuhlis-watermarked report for the patient.
Built on precision medicine
Precision medicine is the first and active sector. The same AI-interpretation core is designed to extend into adjacent industries as they come online.